Skip to content

PROSTATE ONCOLOGY SPECIALISTS

P/ 310-827-7707 | F/ 310-574-4002 | MAIL@PROSTATEONCOLOGY.COM

Menu
  • About
  • Services
  • Prostate Pros
  • Blog
  • Contact

Category: Intermediate Risk

Teal (Intermediate-Risk) is a generally low-grade condition associated with excellent long-term survival, though unlike Sky most men undergo treatment. In addition to all the usual Teal criteria of Gleason 7, PSA from 10-20 or palpable T2b disease, men who qualify for Low-Teal must have only one of these elements. In addition, the Gleason score must be 3+4=7 not 4+3=7, the amount of Grade 4 per the pathology report must be under 20 percent. In addition, no more than two biopsy cores can contain cancer. Many men with Low-Teal can be managed like Sky, that is with active surveillance. The criteria for Basic-Teal (also known as favorable Intermediate-Risk) is like Low-Teal except for having three to six biopsy core containing cancer. High-Teal, also known as unfavorable Intermediate-Risk, is defined by having two or more of the usual Teal criteria or more than 6 biopsy cores that contain cancer.

Verywell logo
Advanced / High Risk / Intermediate Risk / Relapsed

Axumin PET Scans: A Breakthrough for Prostate Cancer

BY MARK SCHOLZ, MD Axumin is an FDA-approved, Medicare-covered scan that can achieve early detection of recurrent prostate cancer after surgery or radiation. For years we have been able to …

Verywell logo
Advanced / Elevated / High Risk / Intermediate Risk / Low Risk / Newly Diagnosed / Prostate Cancer / Undiagnosed

Is It Possible to Substitute a Scan for Prostate Biopsy?

BY MARK SCHOLZ, MD There are two different ways to do a prostate biopsy –  targeted and random. The random 12-core prostate biopsy is standard and has been in use for over …

Verywell logo
Elevated / High Risk / Intermediate Risk / Low Risk / Newly Diagnosed / Prostate Cancer / Undiagnosed

Prostate Biopsy and Alternatives

BY MARK SCHOLZ, MD It seems we have a national passion for prostate biopsies. A million men are biopsied every year. Two hundred thousand of them will be diagnosed with prostate cancer …

Verywell logo
High Risk / Intermediate Risk / Low Risk / Newly Diagnosed

Choosing the Best Prostate Cancer Treatment for You

By Micah Chancey & Mark Scholz, MD Surgery, Radiation, Active Surveillance, or Seed Implant?  Since there are three different risk categories of newly-diagnosed prostate cancer—low, intermediate and high—optimal treatment varies. READ THE FULL …

Verywell logo
High Risk / Intermediate Risk / Low Risk / Prostate Cancer / Relapsed

When PSA Doubling Time Shows a Prostate Cancer Relapse in Men

BY MARK SCHOLZ, MD One cannot really talk intelligently about prostate cancer without a working knowledge of the PSA blood test.  Most people are familiar with using PSA to diagnose prostate …

Advanced / High Risk / Intermediate Risk / Low Risk / Newly Diagnosed / Prostate Cancer / Relapsed

What about Sex after Prostate Surgery?

BY MARK SCHOLZ, MD Only 5-15% of men describe their sexual function as “undiminished” after prostate cancer surgery.[1] And I’ll venture that 0% describe it as improved. If you accept any degree …

Posts navigation

Newer posts

SCHEDULE AN APPOINTMENT

PHONE 310-827-7707
FAX 310-574-4002
mail@prostateoncology.com

  • New Patient Application
  • Education
  • Clinical Trials

Categories

  • Advanced
  • Elevated
  • High Risk
  • Intermediate Risk
  • Low Risk
  • Newly Diagnosed
  • Other
  • Prostate Cancer
  • Relapsed
  • Stages
    • Azure
    • Indigo
    • Royal
    • Sky
    • Teal
  • Undiagnosed

Recent Posts

  • PSA Screening Flowchart
  • A Few Thoughts on Prostatitis
  • Considering Prostate Cancer Clinical Trials? Here’s What You Need to Know
  • Prostate Cancer Spotlights in 2020: A Year in Review
  • Find out about PSMA PET Imaging on Prostate Pros Podcast

Archives

  • April 2021
  • February 2021
  • January 2021
  • December 2020
  • October 2020
  • September 2020
  • August 2020
  • July 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020
  • December 2019
  • November 2019
  • October 2019
  • September 2019
  • August 2019
  • July 2019
  • June 2019
  • May 2019
  • April 2019
  • March 2019
  • January 2019
  • December 2018
  • October 2018
  • September 2018
  • August 2018
  • July 2018
  • June 2018
  • May 2018
  • March 2018
  • January 2018
  • December 2017
  • November 2017
  • October 2017
  • September 2017
  • August 2017
  • July 2017
  • May 2017
  • February 2017
  • November 2016
  • October 2016
  • September 2016
  • August 2016
  • July 2016
  • May 2016
  • April 2016
  • February 2016
  • January 2016
  • October 2015
  • November 2012
  • January 2012
  • April 2011
Join our Newsletter
Keep Updated
Copyright © 2025 PROSTATE ONCOLOGY SPECIALISTS – OnePress theme by FameThemes